118 related articles for article (PubMed ID: 10848789)
1. Role of BCL-2 and cell cycle regulatory proteins for corticosensitivity assessment in childhood acute lymphoblastic leukaemia.
Baghdassarian N; Bertrand Y; Ffrench P; Duhaut P; Bryon PA; Ffrench M
Br J Haematol; 2000 Apr; 109(1):109-16. PubMed ID: 10848789
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2, cell cycle regulatory proteins and corticosensitivity in childhood acute lymphoblastic leukaemia.
Baghdassarian N; Bertrand Y; Gerland LM; Ffrench P; Duhaut P; Bryon PA; Magaud JP; Ffrench M
Leuk Lymphoma; 2001; 42(5):1067-75. PubMed ID: 11697624
[TBL] [Abstract][Full Text] [Related]
3. Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage.
Palle J; Frost BM; Forestier E; Gustafsson G; Nygren P; Hellebostad M; Jonsson OG; Kanerva J; Schmiegelow K; Larsson R; Lönnerholm G;
Br J Haematol; 2005 Apr; 129(2):189-98. PubMed ID: 15813846
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the MLL gene in T-lineage acute lymphoblastic leukemia.
Moorman AV; Richards S; Harrison CJ
Blood; 2002 Sep; 100(6):2273-4. PubMed ID: 12229886
[No Abstract] [Full Text] [Related]
5. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation.
Rubnitz JE; Camitta BM; Mahmoud H; Raimondi SC; Carroll AJ; Borowitz MJ; Shuster JJ; Link MP; Pullen DJ; Downing JR; Behm FG; Pui CH
J Clin Oncol; 1999 Jan; 17(1):191-6. PubMed ID: 10458233
[TBL] [Abstract][Full Text] [Related]
6. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.
Pui CH; Chessells JM; Camitta B; Baruchel A; Biondi A; Boyett JM; Carroll A; Eden OB; Evans WE; Gadner H; Harbott J; Harms DO; Harrison CJ; Harrison PL; Heerema N; Janka-Schaub G; Kamps W; Masera G; Pullen J; Raimondi SC; Richards S; Riehm H; Sallan S; Sather H; Shuster J; Silverman LB; Valsecchi MG; Vilmer E; Zhou Y; Gaynon PS; Schrappe M
Leukemia; 2003 Apr; 17(4):700-6. PubMed ID: 12682627
[TBL] [Abstract][Full Text] [Related]
7. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
[TBL] [Abstract][Full Text] [Related]
8. Infant leukaemia biology, aetiology and treatment.
Greaves MF
Leukemia; 1996 Feb; 10(2):372-7. PubMed ID: 8637251
[No Abstract] [Full Text] [Related]
9. Topoisomerase II inhibitor-related acute myeloid leukaemia.
Pui CH; Relling MV
Br J Haematol; 2000 Apr; 109(1):13-23. PubMed ID: 10848777
[No Abstract] [Full Text] [Related]
10. Molecular analysis of infant acute leukemia.
Hilden JM; Frestedt JL; Kersey JH
Leuk Lymphoma; 1997 Apr; 25(3-4):191-9. PubMed ID: 9168430
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101.
Spijkers-Hagelstein JA; Schneider P; Pinhanços SM; Garrido Castro P; Pieters R; Stam RW
Eur J Cancer; 2014 Jun; 50(9):1665-74. PubMed ID: 24703900
[TBL] [Abstract][Full Text] [Related]
12. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.
Pui CH; Behm FG; Downing JR; Hancock ML; Shurtleff SA; Ribeiro RC; Head DR; Mahmoud HH; Sandlund JT; Furman WL
J Clin Oncol; 1994 May; 12(5):909-15. PubMed ID: 8164041
[TBL] [Abstract][Full Text] [Related]
13. Incidence, clinical characteristics and early treatment outcome in Indian patients of childhood acute lymphoblastic leukemia with ALL-1 gene rearrangement.
Sazawal S; Gurbuxani S; Bhatia K; Khattar A; Raina V; Arya LS; Vats T; Magrath I; Bhargava M
Leuk Res; 2001 Aug; 25(8):693-8. PubMed ID: 11397475
[TBL] [Abstract][Full Text] [Related]
14. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
Wuchter C; Karawajew L; Ruppert V; Schrappe M; Harbott J; Ratei R; Dörken B; Ludwig WD
Br J Haematol; 2000 Jul; 110(1):154-60. PubMed ID: 10930993
[TBL] [Abstract][Full Text] [Related]
15. Acute lymphoblastic leukemia in infants: a decade of experience in the Czech Republic.
Jabali Y; Starý J; Hak J; Blazek B; Hrstkova H; Mihál V; Mydlil J; Timr P; Gajdos P
Med Pediatr Oncol; 2000 Nov; 35(5):493-5. PubMed ID: 11070483
[No Abstract] [Full Text] [Related]
16. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia.
Taki T; Ida K; Bessho F; Hanada R; Kikuchi A; Yamamoto K; Sako M; Tsuchida M; Seto M; Ueda R; Hayashi Y
Leukemia; 1996 Aug; 10(8):1303-7. PubMed ID: 8709635
[TBL] [Abstract][Full Text] [Related]
17. Expression of BCL-2 proto-oncogene in adult acute lymphoblastic leukemia.
Campos L; Sabido O; Sebban C; Charrin C; Bertheas MF; Fière D; Guyotat D
Leukemia; 1996 Mar; 10(3):434-8. PubMed ID: 8642858
[TBL] [Abstract][Full Text] [Related]
18. Rearrangement of the myeloid-lymphoid leukaemia gene in Hong Kong Chinese children with acute leukaemia.
Lit BM; Wong KF; Kwong YL
Hong Kong Med J; 2001 Mar; 7(1):9-14. PubMed ID: 11406670
[TBL] [Abstract][Full Text] [Related]
19. Translocation t(4;11)(q21;q23) and MLL gene rearrangement in acute lymphoblastic leukemia secondary to anti topoisomerase II anticancer agents.
Nasr F; Macintyre E; Venuat AM; Bayle C; Carde P; Ribrag V
Leuk Lymphoma; 1997 Apr; 25(3-4):399-401. PubMed ID: 9168451
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of p16ink4a is associated with a poor prognosis in childhood acute lymphoblastic leukemia.
Mekki Y; Catallo R; Bertrand Y; Manel AM; Ffrench P; Baghdassarian N; Duhaut P; Bryon PA; Ffrench M
Leukemia; 1999 Feb; 13(2):181-9. PubMed ID: 10025891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
